Background: While fibroatheromas (FA) are known to be clinically unstable, the impact of non-FA lesion phenotype on clinical outcomes has not been studied.
methods: In the PROSPECT, pts presenting with acute coronary syndrome underwent 3-vessel grayscale and virtual histology intravascular ultrasound (VH-IVUS) after successful percutaneous intervention for culprit lesions. Pts were divided into those who had only non-FA phenotype (pathological intimal thickening [PIT], fibrotic, and/or fibrocalcific lesions) vs those who had at least 1 non-culprit FA and followed for 3 yrs.
results: Of 609 patients, 67 (11.0%) pts had only non-FA lesion phenotype. Pts with only non-FA tended to be younger and more often female, have fewer non-culprit lesions and less overall plaque burden and necrotic core, and fewer non-culprit lesion major adverse cardiac events (MACE) compared to pts with at least 1 FA (Table) . In the Cox hazards model, absence of a FA was a significant predictive of a lower 3-yr non-culprit-MACE (HR, 0.23; 95%CI, 0.06 to 0.95). Among 2880 non-culprit lesions, 39.8% were non-FA phenotype: 1042 PIT, 72 fibrotic, and 33 fibrocalcific). On a lesion level the rate of 3-yr non-culprit-MACE occurred in only 7 non-FA lesions (0.7%) vs 43 FA lesions (2.7%, p<0.001).
conclusion: Non-FA lesions are clinically stable and are not associated with clinical events at 3 yrs of follow-up. 
